Concord, MA, United States of America

Brad Guild


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2000-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Brad Guild

Introduction

Brad Guild, an accomplished inventor based in Concord, MA, has made significant contributions to the field of gene therapy. With a total of two patents to his name, Guild has focused on developing innovative solutions aimed at treating various disease states through advanced therapeutic methods.

Latest Patents

Brad Guild's latest patents revolve around retroviral gene therapy vectors and the therapeutic methods derived from them. These patents disclose retroviral vectors that include an insertion site for genes of interest, which facilitate the high-level expression of proteins derived from these genes across a wide range of transfected cell types. Notably, these vectors are designed without a selectable marker, making them suitable for human gene therapy without the risk of co-expressing marker products like antibiotics. This innovative approach enhances the therapeutic potential of retroviral vectors, especially in specific packaging cell lines.

Career Highlights

Throughout his illustrious career, Guild has held pivotal roles at notable research institutions. He notably worked at the Whitehead Institute for Biomedical Research and Cell Genesys, Inc., where he advanced his research in gene therapy. His work has laid the groundwork for significant progress in the application of retroviral vectors in medical treatments.

Collaborations

In his professional journey, Brad Guild has collaborated with esteemed colleagues, including Lawrence K. Cohen and Lori F. Rafield. These collaborations have enriched his research endeavors and contributed to the successful development of his patents.

Conclusion

Brad Guild's innovations in retroviral gene therapy exemplify the potential of gene therapy in addressing a variety of diseases. His contributions through patenting advanced therapeutic vectors highlight the importance of continuous research and collaboration in the field of biomedical sciences. The future looks promising for Guild as he continues to make strides in innovative therapies that may change lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…